<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An adult patient suffering from G-CSF-resistant very severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> received a cord blood transplantation from a three-loci HLA-mismatched unrelated donor after nonmyeloablative conditioning </plain></SENT>
<SENT sid="1" pm="."><plain>Cord blood was infused after conditioning with fludarabine (180 mg/m2) and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (100 mg/kg) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> and short-term <z:chebi fb="0" ids="44185">methotrexate</z:chebi> were used for prophylaxis against <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD </plain></SENT>
<SENT sid="3" pm="."><plain>Engraftment was achieved on day 23, and there was no serious GVHD </plain></SENT>
<SENT sid="4" pm="."><plain>A full-donor type T-cell chimerism was obtained by day 30 </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> hematopoiesis and complete chimerism have been maintained 14 months after transplantation </plain></SENT>
</text></document>